Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134673) titled 'Xinhaoyuan Bone Collagen Peptide Powder: Evaluation of Its Effects on Children's Growth and Development, A SingleCenter, SelfControlled Human Feeding Trial' on Oct. 19.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Yan'an University Xianyang Hospital
Condition:
This study has no specific diseases or clinical symptoms, observes the effects of the test substance on growth and development indicators related to height and weight in children, and evaluates its safety and effectiveness for consumption.
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-23 ...